HHMI
CNDT icon

Howard Hughes Medical Institute’s Conduent CNDT Stock Holding History

Howard Hughes Medical Institute’s Portfolio CNDT Stock Details CNDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-35,510
Closed -$566K – 51
2017
Q2 		$566K Buy
+35,510
New +$582K 0.1% 91

Other funds holding CNDT

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.44% 1-Year Est. Return

Howard Hughes Medical Institute's CNDT Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of Conduent (CNDT) in Q3 2017, closing a stake of 35,510 shares — an estimated $566K sold.

Howard Hughes Medical Institute first reported a position in CNDT in Q2 2017 and held it in 1 quarter. The position peaked at $566K in Q2 2017. 297 funds tracked by Wall St. Rank hold CNDT as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining Conduent position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 35,510 Conduent shares in Q3 2017, an estimated $566K.
  • Howard Hughes Medical Institute first reported a position in Conduent in Q2 2017 and held it in 1 quarter.
  • Howard Hughes Medical Institute's Conduent position peaked at $566K in Q2 2017.
  • 297 funds tracked by Wall St. Rank held Conduent as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.